financetom
Business
financetom
/
Business
/
Vivakor Granted Additional 180 Days to Regain Nasdaq Compliance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vivakor Granted Additional 180 Days to Regain Nasdaq Compliance
Sep 17, 2025 8:17 AM

09:02 AM EDT, 09/17/2025 (MT Newswires) -- Vivakor ( VIVK ) said Wednesday that it has received a 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement.

The initial compliance period expired earlier this week, the company said, adding that the extension was granted because Vivakor ( VIVK ) meets all other listing requirements and has committed to resolving the issue through a reverse stock split, if necessary.

The company said it was notified by Nasdaq in March that its shares traded below $1 apiece for 30 consecutive business days.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chewy Insider Sold Shares Worth $4,094,977, According to a Recent SEC Filing
Chewy Insider Sold Shares Worth $4,094,977, According to a Recent SEC Filing
Feb 7, 2025
04:07 PM EST, 02/07/2025 (MT Newswires) -- David Reeder, Chief Financial Officer, on February 05, 2025, sold 107,593 shares in Chewy (CHWY) for $4,094,977. Following the Form 4 filing with the SEC, Reeder has control over a total of 1,087,159 Class A common shares of the company, with 1,087,159 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1766502/000112760225003546/xslF345X05/form4.xml ...
Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing
Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing
Feb 7, 2025
04:09 PM EST, 02/07/2025 (MT Newswires) -- Mikhail Eydelman, Senior Vice President, General Counsel & Corporate Secretary, on February 05, 2025, sold 5,000 shares in Vaxcyte ( PCVX ) for $450,369. Following the Form 4 filing with the SEC, Eydelman has control over a total of 28,222 common shares of the company, with 28,222 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000012/xslF345X05/wk-form4_1738962245.xml...
Update: Entero Therapeutics Gets $2 Million Revolving Loan, Appoints 3 New Board Members
Update: Entero Therapeutics Gets $2 Million Revolving Loan, Appoints 3 New Board Members
Feb 7, 2025
04:01 PM EST, 02/07/2025 (MT Newswires) -- (Updates with the lender in the first paragraph.) Entero Therapeutics ( ENTO ) got a $2 million revolving loan and appointed three new board members designated by the lender, 1396974 BC Ltd., as a condition for the funding. Richard Paolone, Eric Corbett and Manpreet Uppal replaced James Sapirstein, Alastair Riddell and Timothy Ramdeen...
Pimco Flexible Real Estate Income Fund Insider Bought Shares Worth $10,490,000, According to a Recent SEC Filing
Pimco Flexible Real Estate Income Fund Insider Bought Shares Worth $10,490,000, According to a Recent SEC Filing
Feb 7, 2025
04:07 PM EST, 02/07/2025 (MT Newswires) -- Daniel J Ivascyn, 10% Owner, on February 05, 2025, executed a purchase for 1,000,000 shares in Pimco Flexible Real Estate Income Fund (REFLX) for $10,490,000. Following the Form 4 filing with the SEC, Ivascyn has control over a total of 4,138,497 common shares of the company, with 4,058,889 shares held directly and 79,608...
Copyright 2023-2026 - www.financetom.com All Rights Reserved